James Hambro & Partners LLP: EMR position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of James Hambro & Partners LLP on EMR, newest first. How the timeline and the estimate are built.
James Hambro & Partners LLP held 527,066 EMR shares at 2026-06-30 per its 13F-HR filed 2026-07-23.
the latest 13F is the newest step
- period ended2026-06-3013F 527,066 sharesChange vs previous 13F +43,635 shares
2.73% of the 13F portfolio, value $75,425,778.
13F-HR 0001731152-26-000005 filed by James Hambro & Partners LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 483,431 sharesChange vs previous 13F +276,840 shares
2.48% of the 13F portfolio, value $63,356,049.
13F-HR 0001731152-26-000004 filed by James Hambro & Partners LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 206,591 sharesChange vs previous 13F +24,922 shares
0.98% of the 13F portfolio, value $27,421,856.
13F-HR 0001731152-26-000001 filed by James Hambro & Partners LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 181,669 sharesChange vs previous 13F not available
0.85% of the 13F portfolio, value $23,830,431.
13F-HR 0001731152-25-000007 filed by James Hambro & Partners LLP
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).